Continuous nebulization therapy for asthma with aerosols of β2 agonists

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 6, 1998, Pages 499-508

  Raabe, Otto G ^a,b   Wong, Timothy M ^a   Wong, Garrett B ^a   Roxburgh, James W ^a   Piper, S David ^a   Lee, James I C ^a  

^a Vortran Medical Technology Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL; TERBUTALINE SULFATE;

AEROSOL; ARTICLE; ASTHMA; NEBULIZATION; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0031831389     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63074-8     Document Type: Article

References (45)

1. Wood DW, Downes JJ, Scheinkopf H, Lecks HI. Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. J Allergy Clin Immunol 1972;50:75-81.
2. Kurland G, Williams J, Lewiston NJ. Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol 1979;63:407-11.
3. Matson JR, Loughlin GM, Strunk RC. Myocardial ischemia complicating the use of isoproterenol in asthmatic children. J Pediatr 1978;92:776-8.
4. Kadar D, Tang HY, Conn AW. Isoproterenol metabolism in children after intravenous administration. Clin Pharmacol Ther 1974;16:789-95.
5. Paterson JW, Conolly ME, Davies DS, Dillery CT. Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet 1968;2:426-9.
6. Robertson CF, Smith F, Beck R, Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 1985;106:672-4.
7. Pierce RJ, Payne CR, Williams SJ, et al. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest 1981;79:506-11.
8. Lawford P, Jones BJM, Milledge JS. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J 1979;1: 848-50.
9. McCubbin M, Ahrens R, Annis L, VanderMeulen J. Pharmacodynamics and pharmacokinetics of inhaled terbutaline in asthmatic subjects [Abstract]. Am Rev Respir Dis 1987;145: A229.
10. Bierman CW, Shapiro GC, Furukawa CT, Pierson WE. Status asthmaticus. In: Smith, ed. The critically ill child. Philadelphia: WB Saunders, 1986: 299-319.
11. Zeiger RS. Special considerations in the approach to asthma in infancy and early childhood. J Asthma 1983;20: 341-59.
12. Zwerdling RG. Status asthmaticus. Pediatr Ann 1986;15:105-9.
13. Singh M, Kumar L. Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus. Arch Dis Child 1993;69:416-9.
14. Portnoy J, Nadel G, Amado M, Willsie-Ediger S. Continuous nebulization for status asthmaticus. Ann Allergy 1992;69:71-9.
15. 2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988;1101-9.
16. Portnoy J, Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy 1988;60: 368-71.
17. Williams SJ, Winner SJ, Clark TJ. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax 1981;36:629-32.
18. Kelly HW, McWilliams BC, Katz R, Murphy S. Safety of frequent high dose nebulized terbutaline in children with acute severe asthma. Ann Allergy 1990;64:229-33.
19. Colacone A, Wolkove N, Stern E, et al. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest 1990;97:693-7.
20. Katz RW, Kelly HW, Crowley MR, et al. Safety of continuous nebulizer albuterol for bronchospasm in infants and children. Pediatrics 1993;92: 666-9.
21. Olshaker J, Jerrard D, Barish RA, et al. The efficacy and safety of a continuous albuterol protocol for treatment of acute adult asthma attacks. Am J Emerg Med 1993;11:131-3.
22. Levitt MA, Gambrioli EF, Fink JB. Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. Ann Emer Med 1995:273-7.
23. Voss K, Willsie-Ediger S, Pyszxynski D, Nelson KA. Description of a delivery method for continuously aerosolized albuterol in status asthmaticus. J Asthma 1990;27:37-9.
24. Standing CL. Continuous vs. intermittent aerosolized albuterol in the treatment of acute asthma in children. Am Acad Pediatr Abstracts Emerg Med 1994:Abstract #41,50.
25. Ba M, Thivierge RI, Lapierre JG, et al. Effects of continuous inhalation of salbutamol in acute asthma [Abstract]. Am Rev Respir Dis 1987;135:A326.
26. Amado M, Portnoy J, King K. Comparison of bolus and continuously nebulized albuterol for treatment of exacerbations of asthma [Abstract]. J Allergy Clin Immunol 1998;81:318.
27. Craig V, Bigos D, Briglia F, Brilli R. Continuous albuterol therapy in children with status asthmaticus [abstract]. Crit Care Med 1994;22:A182.
28. van Schayck CP, Dompeling E, van Herwaarden CL, et al. Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study. Br J Gen Pract 1995;45: 239-44.
29. Buck ML. Administration of albuterol by continuous nebulization. AACN Clin Issues 1995;6:279-86.
30. Stempel DA, Mellon M. Management of acute severe asthma. Pediatr Clin N Am 1983;31:879-90.
31. Raabe OG. The generation of aerosols of fine particles. In: Liu BYH, ed. Fine particles: aerosol generation, measurement, sampling and analysis. New York: Academic Press, 1976:57-110.
32. Mercer TT, Tillery MI, Chow HY. Operating characteristics of some compressed air nebulizers. Am Indust Hyg Assoc J 1968;29:66-78.
33. Lin RY, Smith AJ, Hergenroeder P. High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. Chest 1993;103:221-5.
34. Bennett NT, Dave J. Treatment of status asthmaticus with continuously aerosolized albuterol. J Respir Care Practitioners 1993:31-2.
35. Raabe OG, Howard RS, Cross CE. Aerosol considerations in asthma. In: Gershwin ME, ed. Bronchial asthma, principles of diagnosis and treatment, 2nd ed. Orlando FL: Grune & Stratton, 1986;495-514.
36. Raabe OG. Deposition and clearance of inhaled particles. In: Gee JB, Kieth W, Morgan C, Brooks SM, ed. Occupational lung diseases. New York: Raven Press, 1984;1-38.
37. Newton GJ, Raabe OG, Mokler BV. Cascade impactor design and performance. J Aerosol Sci 1977;8:339-47.
38. Raabe OG. Aerosol aerodynamic size conventions for inertial sampler calibration. Air Pollution Control Assoc J 1976;26:856-60.
39. Raabe OG. Generation and characterization of aerosols. Inhalation carcinogenesis, CONF-691001. National Technical Information Service, Springfield, Virginia, 1971;123-72.
40. Lin RY, Sauter D, Newman T, et al. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993; 22:1847-53.
41. Chipps BE, Blackney DA, Black LE (III), et al. Vortran high-output extended aerosol respiratory therapy (HEART) for delivery of continuously nebulized terbutaline for the treatment of acute bronchospasm. Pediatr Asthma Allergy Immunol 1990;4: 271-7.
42. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy 1995;75:41-7.
43. Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993;22:1842-6.
44. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21: 1479-86.
45. Ferrante S, Painter E. Continuous nebulization: a treatment modality for pediatric asthma patients. Pediatr Nursing 1995;21:327-31.